Fennec Pharmaceuticals (FENC) Interest Coverage Ratio (2021 - 2025)
Fennec Pharmaceuticals filings provide 7 years of Interest Coverage Ratio readings, the most recent being 7.19 for Q4 2025.
- On a quarterly basis, Interest Coverage Ratio rose 843.12% to 7.19 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.73, a 215.49% decrease, with the full-year FY2025 number at 0.73, down 215.41% from a year prior.
- Interest Coverage Ratio hit 7.19 in Q4 2025 for Fennec Pharmaceuticals, up from 0.32 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 13.29 in Q1 2024 to a low of 1230.75 in Q1 2021.
- Median Interest Coverage Ratio over the past 5 years was 5.08 (2024), compared with a mean of 104.02.
- Biggest five-year swings in Interest Coverage Ratio: crashed 327.17% in 2024 and later skyrocketed 843.12% in 2025.
- Fennec Pharmaceuticals' Interest Coverage Ratio stood at 75.87 in 2021, then surged by 91.15% to 6.71 in 2022, then soared by 70.4% to 1.99 in 2023, then skyrocketed by 51.34% to 0.97 in 2024, then surged by 843.12% to 7.19 in 2025.
- The last three reported values for Interest Coverage Ratio were 7.19 (Q4 2025), 0.32 (Q3 2025), and 4.6 (Q2 2025) per Business Quant data.